Inserm Selects AI-based Clinical Research Tool for Six Month Evaluation Period

Inserm Selects AI-based Clinical Research Tool for Six Month Evaluation Period

The French National Institute of Health and Medical Research, known as Inserm, according to some accounts is the second-leading biomedical research institution worldwide as measured by publications with over 12,000 completed and published annually. With 10,000 researchers investigating everything from public health improvements to novel therapies, the French research powerhouse selected an artificial intelligence-based research tool called Clinical Research Navigator (CRN). Now available for 100 of its researchers, the team will evaluate the research tool for six months.

This news comes by way of the maker of the AI-based research tool called Expert Systems. TrialSite News notes that Inserm didn’t make an outright purchase but rather appears to have settled for a six month pilot. As part of this evaluation, the Inserm researchers will have unlimited access to over 100 million documents and reference information on 12 million clinical studies, including clinical trial data, patents, reports from experts and health organizations, and not to mention web and social network content.

Key Value Proposition

Apparently the differentiating factor for this research tool centers on “...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee